Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Arvee Laboratories (India)'s Enterprise Value is ₹1,668.5 Mil.
Arvee Laboratories (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0.0 Mil. Therefore, Arvee Laboratories (India)'s EV-to-FCF for today is .
The historical rank and industry rank for Arvee Laboratories (India)'s EV-to-FCF or its related term are showing as below:
NSE:ARVEE'
s EV-to-FCF Range Over the Past 10 Years
Min: -79.36 Med: 0 Max: 0
Current: -79.36
NSE:ARVEE's EV-to-FCF is ranked worse than 100% of 932
companies
in the Chemicals industry
Industry Median: 21.49
vs NSE:ARVEE: -79.36
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Arvee Laboratories (India)'s PE Ratio (TTM) for today is calculated as:
Arvee Laboratories (India)'s share price for today is ₹156.72.
Arvee Laboratories (India)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.880.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Arvee Laboratories (India) EV-to-FCF Related Terms
Arvee Laboratories (India) EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Arvee Laboratories (India)'s EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvee Laboratories (India) EV-to-FCF vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Arvee Laboratories (India)'s EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Arvee Laboratories (India)'s EV-to-FCF falls into.
Arvee Laboratories (India)'s current Enterprise Value is ₹1,668.5 Mil.
Arvee Laboratories (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Arvee Laboratories (India) (NSE:ARVEE) Overvalued in 2026?
Based on GuruFocus' analysis, Arvee Laboratories (India) stock appears to be overvalued.
The current stock price of ₹156.72 is trading 26.8% above its estimated GF Value™ of ₹123.63.
GuruFocus considers Arvee Laboratories (India) to be Modestly Overvalued.
Key valuation signals for NSE:ARVEE:
EV-to-FCF:
GF Value™: ₹123.63 vs. price of ₹156.72 (26.8% above fair value)
No single metric tells the full story. See the NSE:ARVEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
75GF Score
Get the complete analysis for NSE:ARVEE
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ARVEE has been successfully added to your 
